Nothing Special   »   [go: up one dir, main page]

Lederman et al., 1981 - Google Patents

Defective suppressor cell generation in juvenile onset diabetes.

Lederman et al., 1981

View PDF
Document ID
9540157728043368479
Author
Lederman M
Ellner J
Rodman H
Publication year
Publication venue
Journal of immunology (Baltimore, Md.: 1950)

External Links

Snippet

Lymphocytes of juvenile onset, insulin-dependent diabetics failed to generate suppressor cell activity after preincubation with concanavalin A (Con A). The mean suppression of the autologous proliferative response to phytohemagglutinin (PHA) was 6.1+/-7.8%(mean+ …
Continue reading at scholar.archive.org (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/564—Immunoassay; Biospecific binding assay for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells

Similar Documents

Publication Publication Date Title
Lederman et al. Defective suppressor cell generation in juvenile onset diabetes.
Greiner et al. Absence of the RT-6 T cell subset in diabetes-prone BB/W rats.
Siegel et al. Deficiency of T helper cells in transient hypogammaglobulinemia of infancy
Yoo et al. Type II collagen autoimmunity in otosclerosis and Meniere's disease
McCarron et al. Presentation of myelin basic protein by murine cerebral vascular endothelial cells.
Lopez et al. A novel mechanism of action for anti-thymocyte globulin: induction of CD4:+: CD25:+: foxp3:+: regulatory T cells
Weetman et al. Autoimmune thyroid disease: further developments in our understanding
Fowell et al. Evidence that the T cell repertoire of normal rats contains cells with the potential to cause diabetes. Characterization of the CD4+ T cell subset that inhibits this autoimmune potential.
MacKenzie et al. Intrathyroidal T cell clones from patients with autoimmune thyroid disease
MacKay et al. Spontaneous diabetes mellitus in the Bio-Breeding/Worcester rat. Evidence in vitro for natural killer cell lysis of islet cells.
Horita et al. Abnormalities of immunoregulatory T cell subsets in patients with insulin-dependent diabetes mellitus.
Bottazzo et al. Separate autoantibodies to human pancreatic glucagon and somatostatin cells
Eguchi et al. Increment in the Ta1+ cells in the peripheral blood and thyroid tissue of patients with Graves' disease.
Ozkan et al. HLA antigens in Turkish race with rheumatic heart disease [see comment].
Cohen et al. Limiting dilution analysis of the frequency of antigen-reactive lymphocytes isolated from the central nervous system of Lewis rats with experimental allergic encephalomyelitis
Vialettes et al. Autoimmune polyendocrine failure—Type 1 (insulin-dependent) diabetes mellitus and hypothyroidism—after allogenic bone marrow transplantation in a patient with lymphoblastic leukaemia
Krömer et al. Analysis of lymphocytes infiltrating the thyroid gland of Obese strain chickens.
Fairchild et al. Specific immunoregulation abnormality in insulin-dependent diabetes mellitus
McCombe et al. Inflammatory cells, microglia and MHC class II antigen-positive cells in the spinal cord of Lewis rats with acute and chronic relapsing experimental autoimmune encephalomyelitis
Bogner et al. Thyroid cytotoxic antibodies in atrophic and goitrous autoimmune thyroiditis
Burns et al. A human leukaemic cell expressing hybrid membrane phenotypes
Bagnasco et al. Graves' disease: phenotypic and functional analysis at the clonal level of the T-cell repertoire in peripheral blood and in thyroid
Moore et al. In vitro regulation of the pathogenic autoantibody response of New Zealand black mice. I. Loss with age of suppressive activity in T cell populations.
Geissler et al. HUMAN LIVER ALLOGRAFT ACCEPTANCE AND THE “TOLERANCE ASSAY”: IN VITRO ANTI-DONOR T CELL ASSAYS SHOW HYPOREACTIVITY TO DONOR CELLS, BUT UNLIKE DTH, FAIL TO DETECT LINKED SUPPRESSION1
Kimura et al. Thyroid-specific T cells in the normal Wistar rat: II. T cell clones interact with cloned Wistar rat thyroid cells and provide direct evidence for autoantigen presentation by thyroid epithelial cells